{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:24:20Z","timestamp":1784366660192,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eclinm.2024.102526","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T08:31:11Z","timestamp":1710145871000},"page":"102526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0927","authenticated-orcid":false,"given":"Martin","family":"Cornillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"von Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102526_bib1","first-page":"1144","article-title":"Retrecissement du choledoque: cholecystoduo-denostomie","volume":"50","author":"Delbet","year":"1924","journal-title":"Bull Mem Soc Nat Chir"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102526_bib2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"issue":"10139","key":"10.1016\/j.eclinm.2024.102526_bib3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102526_bib4","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2013a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cld.672","article-title":"Primary sclerosing cholangitis: unique aspects of disease in children","volume":"10","author":"Cotter","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2050640617717156","article-title":"Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis","volume":"6","author":"Rupp","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","article-title":"Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation","volume":"31","author":"Visseren","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102526_bib12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102526_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cld.2015.08.005","article-title":"Primary sclerosing cholangitis: multiple phenotypes, multiple approaches","volume":"20","author":"Sarkar","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102526_bib17","article-title":"Systematic review of prognostic models compared to the Mayo risk score for primary sclerosing cholangitis","volume":"10","author":"Schmeltzer","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"23","key":"10.1016\/j.eclinm.2024.102526_bib18","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"issue":"10319","key":"10.1016\/j.eclinm.2024.102526_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","article-title":"Liquid biopsies in cancer diagnosis, monitoring, and prognosis","volume":"40","author":"De Rubis","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"24","key":"10.1016\/j.eclinm.2024.102526_bib22","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMe2204625","article-title":"Liquid biopsy for precision adjuvant chemotherapy in colon cancer","volume":"386","author":"Montagut","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trecan.2020.11.001","article-title":"Next-generation liquid biopsies: embracing data science in oncology","volume":"7","author":"Im","year":"2021","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102526_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41571-020-0420-0","article-title":"Methylation extends the reach of liquid biopsy in cancer detection","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"6538","key":"10.1016\/j.eclinm.2024.102526_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-022-01526-8","article-title":"Proteomics technologies for cancer liquid biopsies","volume":"21","author":"Ding","year":"2022","journal-title":"Mol Cancer"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102526_bib27","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41587-023-01714-x","article-title":"Global detection of human variants and isoforms by deep proteome sequencing","volume":"41","author":"Sinitcyn","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102526_bib28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1038\/s41591-022-02104-7","article-title":"Impact of the human cell atlas on medicine","volume":"28","author":"Rood","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2020.08.036","article-title":"A\u00a0quantitative proteome map of the human body","volume":"183","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"6509","key":"10.1016\/j.eclinm.2024.102526_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Consortium","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102526_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"7837","key":"10.1016\/j.eclinm.2024.102526_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"issue":"10250","key":"10.1016\/j.eclinm.2024.102526_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102526_bib37","first-page":"10","article-title":"Sex differences in biological aging with a focus on human studies","author":"Hagg","year":"2021","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamasurg.2013.1221","article-title":"The Swedish registry of gallstone surgery and endoscopic retrograde Cholangiopancreatography (GallRiks): a nationwide registry for quality assurance of gallstone surgery","volume":"148","author":"Enochsson","year":"2013","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib40","first-page":"235","article-title":"Long term effect of simvastatin in primary sclerosing cholangitis: a placebo-controlled, double blind multicentre phase III study (Piscatin)","volume":"4","author":"Bergquist","year":"2022","journal-title":"Br J Gastroenterol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","volume":"78","author":"Villard","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102526_bib44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102526_bib45","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","article-title":"A\u00a0novel prognostic model for transplant-free survival in primary sclerosing cholangitis","volume":"67","author":"de Vries","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib46","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.30085","article-title":"Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.31393","article-title":"The sclerosing cholangitis outcomes in pediatrics (SCOPE) index: a prognostic tool for children","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.eclinm.2024.102526_bib50","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.cgh.2019.03.013","article-title":"Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis","volume":"17","author":"Lemoinne","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2019.06.012","article-title":"Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis","volume":"71","author":"Goet","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102526_bib52","article-title":"Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis","volume":"4","author":"Grigoriadis","year":"2022","journal-title":"JHEP Rep"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102526_bib53","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.3748\/wjg.v20.i12.3245","article-title":"Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?","volume":"20","author":"Nakazawa","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102526_bib54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102526_bib55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102526_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102526_bib58","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib59","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102526_bib60","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/liv.15650","article-title":"Patient-reported quality of care in primary sclerosing cholangitis","volume":"43","author":"Walmsley","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102526_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.eclinm.2024.102526_bib62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMp2200089","article-title":"Real-world evidence\u2013where are we now?","volume":"386","author":"Concato","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102526_bib63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.annonc.2021.12.015","article-title":"External control arms in oncology: current use and future directions","volume":"33","author":"Mishra-Kalyani","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eclinm.2024.102526_bib64","article-title":"Application of real-world data to external control groups in oncology clinical trial drug development","volume":"11","author":"Yap","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102526_bib65","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/d41573-020-00146-5","article-title":"Informing single-arm clinical trials with external controls","volume":"19","author":"Davi","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"7855","key":"10.1016\/j.eclinm.2024.102526_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41586-021-03430-5","article-title":"Evaluating eligibility criteria of oncology trials using real-world data and AI","volume":"592","author":"Liu","year":"2021","journal-title":"Nature"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:06:23Z","timestamp":1762632383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":66,"alternative-id":["S2589537024001056"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102526","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102526"}}